文献
J-GLOBAL ID:201402201376412382
整理番号:14A0294078
去勢抵抗性前立腺癌の患者におけるアンドロゲン受容体mRNAのエクソン4に結合した核酸アンチセンスオリゴヌクレオチドであるEZN-4176のヒト初回投与第I相試験(First-in-human Phase I study)
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
著者 (36件):
BIANCHINI D
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
BIANCHINI D
(Center for Prostate and Urologic Cancers, NY, USA)
,
OMLIN A
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
OMLIN A
(Center for Prostate and Urologic Cancers, NY, USA)
,
PEZARO C
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
PEZARO C
(Center for Prostate and Urologic Cancers, NY, USA)
,
LORENTE D
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
LORENTE D
(Center for Prostate and Urologic Cancers, NY, USA)
,
FERRALDESCHI R
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
FERRALDESCHI R
(Center for Prostate and Urologic Cancers, NY, USA)
,
MUKHERJI D
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
MUKHERJI D
(Center for Prostate and Urologic Cancers, NY, USA)
,
CRESPO M
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
CRESPO M
(Center for Prostate and Urologic Cancers, NY, USA)
,
FIGUEIREDO I
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
FIGUEIREDO I
(Center for Prostate and Urologic Cancers, NY, USA)
,
MIRANDA S
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
MIRANDA S
(Center for Prostate and Urologic Cancers, NY, USA)
,
RIISNAES R
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
RIISNAES R
(Center for Prostate and Urologic Cancers, NY, USA)
,
ZIVI A
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
ZIVI A
(Center for Prostate and Urologic Cancers, NY, USA)
,
BUCHBINDER A
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
BUCHBINDER A
(Center for Prostate and Urologic Cancers, NY, USA)
,
RATHKOPF D E
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
RATHKOPF D E
(Center for Prostate and Urologic Cancers, NY, USA)
,
ATTARD G
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
ATTARD G
(Center for Prostate and Urologic Cancers, NY, USA)
,
SCHER H I
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
SCHER H I
(Center for Prostate and Urologic Cancers, NY, USA)
,
BONO J de
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
BONO J de
(Center for Prostate and Urologic Cancers, NY, USA)
,
BONO J de
(ENZON Pharmaceuticals Inc., Bridgewater, NJ, USA)
,
DANILA D C
(Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR)
,
DANILA D C
(Center for Prostate and Urologic Cancers, NY, USA)
,
DANILA D C
(ENZON Pharmaceuticals Inc., Bridgewater, NJ, USA)
資料名:
British Journal of Cancer
(British Journal of Cancer)
巻:
109
号:
10
ページ:
2579-2586
発行年:
2013年11月12日
JST資料番号:
C0922B
ISSN:
0007-0920
資料種別:
逐次刊行物 (A)
発行国:
イギリス (GBR)
言語:
英語 (EN)